SEO report of vivanls.com

• "life sciences" / 16
• "drug administration" / 11
• "food drug" / 11
• "administration fda" / 10
• "vivan life" / 7
• "orally disintegrating" / 6
• "drug application" / 6
• "disintegrating tablets" / 6
• "final approval" / 5
• "enforcement policy" / 4

• "food drug administration" / 11
• "drug administration fda" / 10
• "vivan life sciences" / 7
• "orally disintegrating tablets" / 6
• "jubilant life sciences" / 4
• "abbreviated drug application" / 4
• "drug application anda" / 4
• "fda rizatriptan benzoate" / 3
• "benzoate orally disintegrating" / 3
• "rizatriptan benzoate orally" / 3

• Name:
  Content: http://vivanls.com/image/cache/data/vivan_logo-200x200.png
• Name: google-translate-customization
  Content: bbd4d0c5d532dc7-130fe793a60f68f4-g175d762a9800bcae-f
• Name: viewport
  Content: width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no
• Name: format-detection
  Content: telephone=no
• Name: description
  Content: Drug Reference Standards - "Analytical Reference Standards" products with highly characterized as well as best quality.

We found a total of 168 different links.

External dofollow

Number of External dofollow links: 60

• Href: /NewsDetails.aspx
  Title: Skin Bank to be launched by Masina Hospital, Mumbai
  Count: 1
• Href: /NewsDetails.aspx
  Title: GE partners with USAID for India's Healthcare needs
  Count: 1
• Href: /NewsDetails.aspx
  Title: Telangana-‘Bulk drug manufacturing hub of India'
  Count: 1
• Href: /NewsDetails.aspx
  Title: Amgen launches online media resource
  Count: 1
• Href: /NewsDetails.aspx
  Title: Allergan collaborates with Novartis
  Count: 1
• Href: /NewsDetails.aspx
  Title: Phagelux collaborates with Johnson & Johnson
  Count: 1
• Href: /news/your-money/article-fmcg-highest-paying-industry-with-average-pay-of-rs-11-lakh-survey-1678204
  Title: Survey brings FMCG as the highest paying industry
  Count: 1
• Href: /sectors/pharma/cipla-bets-respiratory-oncology-and-hiv-segments-brazil-china/story/246961.html
  Title: Cipla bets on respiratory, oncology and HIV segments in Brazil and China
  Count: 1
• Href: /NewsDetails.aspx
  Title: Cipla receives final approval for generic Epzicom tablets
  Count: 1
• Href: /NewsDetails.aspx
  Title: India & Netherlands to begin a Research
  Count: 1
• Href: /sectors/pharma/abbott-to-make-india-hub-of-global-research-and-development-for-branded-generics/story/244621.html
  Title: Abbott to make India hub of global research and development for branded generics
  Count: 1
• Href: /sectors/pharma/lupin-gets-usfda-nod-to-market-cancer-drug/story/247096.html
  Title: Alembic Pharma's partner launches drug for depressive disorder
  Count: 1
• Href: /news/boehringer_signs_copd_research_deal_with_weill_1186847
  Title: Boehringer signs COPD research deal with Weill
  Count: 1
• Href: /in-the-news/in-the-news-details.aspx
  Title: Project Nanhi Kali at the Standard Chartered Mumbai Marathon, 2017
  Count: 1
• Href: /Clinical-Development/Pharm-Olam-nabs-PE-investment-amid-market-void-for-mid-tier-CROs
  Title: Pharm-Olam nabs PE investment amid 'market void' for mid-tier CROs
  Count: 1
• Href: /NewsDetails.aspx
  Title: US FDA accepts Intarcia's NDA for ITCA 650 to treat type 2 diabetes
  Count: 1
• Href: /Commercial-Services/Almac-launches-TempEZ-temperature-management-software
  Title: Almac launches temperature management software
  Count: 1
• Href: /Regulatory-Safety/Cannabis-grower-gains-EMA-GMP-status-for-Dutch-plants
  Title: GMP-status 'a major step' for medical marijuana recognition, Bedrocan
  Count: 1
• Href: /Regulatory-Safety/Trump-names-Robert-F.-Kennedy-Jr-to-vaccine-commission
  Title: Trump names chair of vaccine commission to examine 'scientific integrity';
  Count: 1
• Href: /NewsDetails.aspx
  Title: Bayer's regorafenib receives US FDA Priority Review status for second-line treatment of liver cancer;
  Count: 1
• Href: /sectors/pharma/indian-pharma-industry-facing-growth-headwinds-icra/story/241983.html
  Title: Indian pharma industry facing growth headwinds;
  Count: 1
• Href: /vaccines/parker-institute-cancer-research-institute-team-up-to-develop-cancer-vaccines
  Title: Parker Institute, Cancer Research Institute team up on neoantigen-based cancer vaccines;
  Count: 1
• Href: /research/3706-greater-efforts-are-needed-to-encourage-patients-to-report-adverse-drug-reactions
  Title: Greater efforts are needed to encourage patients to report adverse drug reactions;
  Count: 1
• Href: /industry/healthcare/biotech/pharmaceuticals/lupin-launches-amabelz-tablets-in-us-market/articleshow/55439186.cms
  Title: Lupin launches Amabelz tablets in US market;
  Count: 1
• Href: /city/nashik/FDA-to-crack-whip-on-pharma-companies/articleshow/55344029.cms
  Title: FDA to crack whip on pharma companies;
  Count: 1
• Href: /news/eisai_kicks_off_mid-stage_study_of_sleep_drug_1175910
  Title: Eisai kicks off mid-stage study of sleep drug;
  Count: 1
• Href: /news/old-blood-good-new-transfusions-study-finds-63165.html
  Title: Using the freshest blood for transfusions does not appear to boost patient survival, a new Canadian study indicates.;
  Count: 1
• Href: /newdrugs/fda-grants-accelerated-approval-lartruvo-olaratumab-advanced-soft-tissue-sarcoma-4446.html
  Title: FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma;
  Count: 1
• Href: /manufacturing/chinese-api-makers-look-to-move-up-value-chain
  Title: Chinese API makers look to move up the value chain;
  Count: 1
• Href: /vaccines/sanofi-grabs-43m-u-s-government-funds-for-zika-vaccine-r-d
  Title: Sanofi grabs $43M in U.S. government funds to advance Zika vaccine into Phase II;
  Count: 1
• Href: /article/markets/chart-check-power-grid-pidilite-bharat-financial-aurobindo-pharma-116090700128_1.html
  Title: Power Grid, Pidilite, Bharat Financial, Aurobindo Pharma.;
  Count: 1
• Href: /sectors/pharma/now-a-paper-based-device-can-spot-poor-quality-medicines/story/236379.html
  Title: Now, a paper-based device can spot poor-quality medicines;
  Count: 1
• Href: /NewsDetails.aspx
  Title: HarlePhil Ventures to market Biocept's liquid biopsy tests in Philippines;
  Count: 1
• Href: /NewsDetails.aspx
  Title: Cipla appoints Kedar Upadhye as global CFO;
  Count: 1
• Href: /media/fmc-elects-current-director-as-new-vice-president/10191.html
  Title: FMC elects current director as new vice president >
  Count: 1
• Href: /news/globaldata-expects-ipf-market-to-more-than-treble-to-32bn-by-2025-220616-4930247
  Title: GlobalData expects IPF market to more than treble to $3.2bn by 2025 >
  Count: 1
• Href: /merckgroup/3514-merck-in-agreement-with-happyneuron-to-offer-first-of-its-kind-e-health-solution-for-people-living-with-multiple-sclerosis
  Title: Merck, a leading science and technology company, announced today that the company has entered into an agreement with HAPPYneuron, >
  Count: 1
• Href: /boehringer-ingelheim/3497-boehringer-ingelheim-increases-access-to-the-medication-for-the-treatment-of-hiv-aids
  Title: Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg and 10 mg, the generic version of Maxalt-MLT Orally Disintegrating, 5 mg and 10 mg Tablets (of Merck), which is indicated for the acute treatment of migraine in adults and in pediatric patients;
  Count: 2
• Href: /news/buzzing-stocks/sms-pharma-rises-12usfda-nod-for-andhra-pradesh-plant_4754061.html
  Title: GlaxoSmithKline (GSK) has agreed to acquire Bristol-Myers Squibb's (BMS) pipeline of research and development (R&D) HIV assetsfor about $1.5bn;
  Count: 2
• Href: /news/teva-wins-approval-for-copaxone-to-prevent-relapse-of-multiple-sclerosis
  Title: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Teva Pharmaceutical Industries' once-daily COPAXONE (glatiramer acetate injection) 20mg injection for the prevention of relapse of multiple sclerosis;
  Count: 1
• Href: /news/nice-recommends-bristol-myers-squibbs-daklinza-to-treat-chronic-hepatitis-c-virus-infection
  Title: Bristol-Myers Squibb announced that the National Institute for Health and Care Excellence (NICE) has recommended Daklinza (daclatasvir) in England and Wales for the treatment of adult patients with chronic hepatitis C virus (HCV) infection;
  Count: 1
• Href: /news/jubilant-life-sciences-wins-anda-approval-for-rizatriptan-benzoate-od-tablets
  Title: Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg and 10 mg, the generic version of Maxalt-MLT Orally Disintegrating, 5 mg and 10 mg Tablets (of Merck), which is indicated for the acute treatment of migraine in adults and in pediatric patients;
  Count: 1
• Href: /news/fda-approves-merrimacks-metastatic-pancreatic-cancer-drug
  Title: The US Food and Drug Administration (FDA) has approved Merrimack Pharmaceuticals’ metastatic pancreatic cancer drug, Onivyde;
  Count: 1
• Href: /news/worlds-largest-aspirin-anti-cancer-trial-launches-in-uk
  Title: The world's largest clinical trial to see whether taking a daily dose of aspirin can stop cancer from recurring has been launched in the UK;
  Count: 1
• Href: /Clinical-Development/Pfizer-Allergan-deal-report-prompts-speculation-about-fallout-for-CROs
  Title: Reports Pfizer is considering buying Allergan to create a company worth $330bn have once again raised fears of disruption for contract research organisations (CRO), although there are reasons to think the deal would be less troublesome than earlier megamergers;
  Count: 1
• Href: /Commercial-Services/Hanson-Shimadzu-combine-techs-to-create-an-automated-testing-system
  Title: Hanson Research and Shimadzu have teamed up to combine their respective technologies into an automated online pharmaceutical testing system;
  Count: 1
• Href: /news/hvivo-invests-in-prep-biopharm
  Title: hVIVO has made an investment in the UK-based start-up, PrEP Biopharm, to further develop new prophylactic treatment for respiratory infections;
  Count: 1
• Href: /news/tara-immuno-oncology-acquires-licenses-to-develop-clinical-stage-p53mva-oncology-vaccine
  Title: Tara Immuno-Oncology has acquired licenses from City of Hope for the development of p53MVA (modified vaccinia ankara) and a Salmonella-based therapy targeting Indoleamine 2,3-Dioxygenase (shIDO-ST), both for multiple oncology indication;
  Count: 1
• Href: /news/fda-approves-gilead-sciences-genvoya-hiv-drug
  Title: The US Food and Drug Administration (FDA) has approved Gilead Sciences' Genvoya HIV drug to treat patients aged 12 and above;
  Count: 1
• Href: /news/leo-pharma-to-buy-astellas-pharmas-global-dermatology-portfolio
  Title: LEO Pharma has agreed to acquire Astellas Pharma's global dermatology business for €675m;
  Count: 1
• Href: /news/emerson-ge-healthcare-partner-to-increase-biopharma-manufacturing-efficiency
  Title: Emerson Process Management has partnered with GE Healthcare’s Life Sciences business to increase productivity and improve efficiency in the production of biopharmaceuticals;
  Count: 1
• Href: /news/astrazeneca-agrees-to-sell-us-rights-for-entocort-drug-to-perrigo
  Title: AstraZeneca has agreed to sell the US rights for its gastrointestinal drug Entocort to Perrigo for $380m;
  Count: 1
• Href: /Processing/Acquired-Sigma-Aldrich-businesses-part-of-Merck-s-Africa-growth-plan
  Title: New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck;
  Count: 1
• Href: /siteinfo/vivanls.com
  Count: 1
• Href: /pages/Vivan-Life-Sciences/113367155401014
  Count: 1
• Href: /VIVANLS
  Count: 1
• Href: /115202175860750737788/posts
  Count: 1
• Href: /watch
  Count: 1
• Href: /company/vivan-life-sciences-pvt.-limited
  Count: 1
• Href: /photos/94036776@N02/sets
  Count: 1

Internal dofollow

Number of Internal dofollow links: 108

• Href: /index.php
  Title: Login
  Count: 1
• Href: /index.php
  Title: Register
  Count: 1
• Href: /index.php
  Title: Wish List (0)
  Count: 1
• Href:
  Count: 6
• Href: /about-us
  Title: About Us
  Count: 1
• Href: /our-vision
  Title: Our Vision
  Count: 1
• Href: /ipr-practices
  Title: IPR Practices
  Count: 1
• Href: /vivan-and-logo
  Title: VIVAN & Logo
  Count: 1
• Href: /business-units
  Title: Business Units
  Count: 1
• Href: index.php
  Title: Photo Gallery
  Count: 2
• Href: /safety-amp-environment-protection-policy
  Title: Safety & Environment
  Count: 1
• Href: /neurons
  Title: Neurons
  Count: 1
• Href: /corporate-governance
  Title: Corporate
  Count: 2
• Href: /our-mission
  Title: Mission
  Count: 1
• Href: /corporate-strategy
  Title: Corporate Strategy
  Count: 1
• Href: /culture-and-values
  Title: Culture & Values
  Count: 1
• Href: /support-network
  Title: Support Network
  Count: 1
• Href: /vivan-s-csr
  Title: Social Responsibility
  Count: 3
• Href: /products
  Title: Products
  Count: 1
• Href: /clinical-diagnostic-r-amp-d-center
  Title: R & D Center
  Count: 1
• Href: /deuterated-internal-standard-analytical-labs
  Title: Analytical Labs
  Count: 1
• Href: /careers-at-vivan-bio-availability-and-bio-equivalence-clinical-trial-ba-be-studies
  Title: Careers
  Count: 2
• Href: /index.php
  Title: Why VIVAN
  Count: 1
• Href: /working-with-vivan
  Title: Working With VIVAN
  Count: 1
• Href: /how-we-work
  Title: How We Work
  Count: 1
• Href: /work-practice-amp-ethics
  Title: Work Practice & Ethics
  Count: 1
• Href: /bio-availability-and-bio-equivalence-clinical-trial-ba-be-studies
  Title: Internship @ VIVAN
  Count: 1
• Href: /our-culture
  Title: Our Culture
  Count: 1
• Href: /alumni-network
  Title: Alumni Network
  Count: 1
• Href: /leadership-in-making
  Title: Leadership In Making
  Count: 1
• Href: /work-life-balance
  Title: Work Life Balance
  Count: 1
• Href: /crisil-verified
  Title: CRISIL Verified
  Count: 1
• Href: /crisil-sme-ratings
  Title: NSIC-CRISIL MSE Ratings
  Count: 1
• Href: /crisil-is-a-global-analytical-company
  Title: CRISIL- SME Ratings
  Count: 1
• Href: /d-amp-b-d-u-n-s-number
  Title: D&B D-U-N-S Number
  Count: 1
• Href: /index.php
  Count: 1
• Href: /index.php
  Count: 1
• Href: /index.php
  Title: -> Child Labor & Education
  Count: 1
• Href: /index.php
  Title: -> Grow Trees
  Count: 1
• Href: /index.php
  Title: -> Re- Think
  Count: 1
• Href: /index.php
  Title: -> Reduce your Trash
  Count: 1
• Href: /index.php
  Title: -> Save Energy Save Electricity
  Count: 1
• Href: /index.php
  Title: -> Save paper Save trees
  Count: 1
• Href: /index.php
  Title: -> Save water save life
  Count: 1
• Href: /index.php
  Title: -> Things one must know
  Count: 1
• Href: /contact-us
  Title: Contact Us
  Count: 1
• Href:
  Title: http://www.vivanls.com
  Count: 1
• Href: info@vivanls.com
  Title: info@vivanls.com
  Count: 1
• Href: /
  Title: Blog
  Count: 1
• Href: /drug-reference-standards
  Title: Drug Reference Standards : VIVAN Life Sciences
  Count: 1
• Href: /deuterium-labeled-compounds
  Title: Deuterium Labeled Compounds
  Count: 1
• Href: /metabolites
  Title: LC-MS/MS Method Validation| Metabolites
  Count: 1
• Href: /drug-impurities
  Title: Impurities | Quantitative Bioanalytical Methods
  Count: 1
• Href: /glucuronides
  Title: Glucuronides | HPLC-MS/MS Method Validation
  Count: 1
• Href: /chiral-standards
  Title: Chiral Standards
  Count: 1
• Href: /index.php
  Title:   #  
  Count: 1
• Href: /index.php
  Title:   A  
  Count: 1
• Href: /index.php
  Title:   B  
  Count: 1
• Href: /index.php
  Title:   C  
  Count: 1
• Href: /index.php
  Title:   D  
  Count: 1
• Href: /index.php
  Title:   E  
  Count: 1
• Href: /index.php
  Title:   F  
  Count: 1
• Href: /index.php
  Title:   G  
  Count: 1
• Href: /index.php
  Title:   H  
  Count: 1
• Href: /index.php
  Title:   I  
  Count: 1
• Href: /index.php
  Title:   J  
  Count: 1
• Href: /index.php
  Title:   K  
  Count: 1
• Href: /index.php
  Title:   L  
  Count: 1
• Href: /index.php
  Title:   M  
  Count: 1
• Href: /index.php
  Title:   N  
  Count: 1
• Href: /index.php
  Title:   O  
  Count: 1
• Href: /index.php
  Title:   P  
  Count: 1
• Href: /index.php
  Title:   Q  
  Count: 1
• Href: /index.php
  Title:   R  
  Count: 1
• Href: /index.php
  Title:   S  
  Count: 1
• Href: /index.php
  Title:   T  
  Count: 1
• Href: /index.php
  Title:   U  
  Count: 1
• Href: /index.php
  Title:   V  
  Count: 1
• Href: /index.php
  Title:   W  
  Count: 1
• Href: /index.php
  Title:   X  
  Count: 1
• Href: /index.php
  Title:   Y  
  Count: 1
• Href: /index.php
  Title:   Z  
  Count: 1
• Href: /levomefolate-d4
  Count: 2
• Href: /amoxicillin-d4
  Count: 2
• Href: /quinine-d3
  Count: 2
• Href: iframe.html
  Count: 1
• Href: /
  Count: 1
• Href: /index.php
  Count: 1
• Href: /index.php
  Count: 2
• Href: /image/cache/data/gallery/2016/1-2016-700x394.png
  Count: 1
• Href: /image/cache/data/gallery/2016/4-2016-700x394.png
  Count: 1
• Href: /image/cache/data/gallery/2016/5-2016-700x394.png
  Count: 2
• Href: /image/cache/data/gallery/2016/6-2016-700x394.png
  Count: 1
• Href: /image/cache/data/gallery/2016/2-2016-700x394.png
  Count: 1
• Href: /image/cache/data/gallery/right gallery img/12-700x394.jpg
  Count: 1
• Href: /image/cache/data/gallery/2016/8-2016-700x394.png
  Count: 1
• Href: /image/cache/data/gallery/2016/9-2016-700x394.png
  Count: 1
• Href:
  Title: How To Order
  Count: 1
• Href:
  Title: How To Pay
  Count: 1
• Href:
  Title: Products Dispatch
  Count: 1
• Href:
  Count: 2
• Href: /index.php
  Count: 1
• Href: /index.php
  Count: 1
• Href: /index.php
  Count: 1
• Href: index.php
  Title: -Read More
  Count: 1
• Href: /privacy-policy-2
  Title: Privacy Policy
  Count: 1
• Href: /disclaimer
  Title: Disclaimer
  Count: 1
• Href: /index.php
  Title: Site Map
  Count: 1

ivanls.com, vivanls.com, ivanls.com, vcivanls.com, civanls.com, vdivanls.com, divanls.com, vfivanls.com, fivanls.com, vgivanls.com, givanls.com, vbivanls.com, bivanls.com, v ivanls.com, ivanls.com, vvanls.com, viuvanls.com, vuvanls.com, vijvanls.com, vjvanls.com, vivanls.com, vvanls.com, vilvanls.com, vlvanls.com, viovanls.com, vovanls.com, vi8vanls.com, v8vanls.com, vi9vanls.com, v9vanls.com, vi*vanls.com, v*vanls.com, vianls.com, vivanls.com, vianls.com, vivcanls.com, vicanls.com, vivdanls.com, vidanls.com, vivfanls.com, vifanls.com, vivganls.com, viganls.com, vivbanls.com, vibanls.com, viv anls.com, vi anls.com, vivnls.com, vivaqnls.com, vivqnls.com, vivawnls.com, vivwnls.com, vivaznls.com, vivznls.com, vivanls.com, vivnls.com, vivaxnls.com, vivxnls.com, vivasnls.com, vivsnls.com, vivals.com, vivanbls.com, vivabls.com, vivangls.com, vivagls.com, vivanhls.com, vivahls.com, vivanjls.com, vivajls.com, vivanmls.com, vivamls.com, vivan ls.com, viva ls.com, vivans.com, vivanlps.com, vivanps.com, vivanlos.com, vivanos.com, vivanls.com, vivans.com, vivanlis.com, vivanis.com, vivanlks.com, vivanks.com, vivanlms.com, vivanms.com, vivanl.s.com, vivan.s.com, vivanl.com, vivanlsq.com, vivanlq.com, vivanlsw.com, vivanlw.com, vivanlse.com, vivanle.com, vivanlsz.com, vivanlz.com, vivanlsx.com, vivanlx.com, vivanlsc.com, vivanlc.com